Bruker Biospin GmbH & Co KG

Bruker Biospin GmbH & Co KG is a company in Ettlingen, Germany that has taken part in 9 EU-funded projects since 2017, receiving €1.8M in EU funding.

EU funding received€1.8M
EU projects9
As coordinator0
Running now5
First EU project2017
Latest project2026
CountryGermany
EU registration (PIC)880012907
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bruker Biospin GmbH & Co KG's own share of each project, not the project's full budget.

  • Horizon Europe€1.8M · 6 projects
  • Horizon 2020€49k · 3 projects

Projects

9 EU-funded projects, newest first. Each links to the official record.

  • LIPAGGAssociated partner

    From biophysical chemistry to cell biology: Deciphering the role of lipids in the toxicity and spreading of protein aggregation

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • SPACERAssociated partner

    Shaping Porous Electrode Architecture to Improve Current Density and Energy Efficiency in Redox Flow Batteries

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • IQ-BRAINPartner

    Improving QMRI By Realizing trustworthy integration of AI in Neuro-imaging

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €261ktheir share
  • Fragment-ScreenPartner

    From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.2Mtheir share
  • CoDietPartner

    COMBATTING DIET RELATED NON-COMMUNICABLE DISEASE THROUGH ENHANCED SURVEILLANCE

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €314ktheir share
  • R-NMRPartner

    Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €26ktheir share
  • PANACEAPartner

    A Pan-European Solid-State NMR Infrastructure for Chemistry-Enabling Access

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • HIRES-MULTIDYNPartner

    Multiscale Dynamics with Ultrafast High-Resolution Relaxometry

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €49ktheir share
  • IB4SD-TRISTANPartner

    Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • absorption spectroscopy
  • additive manufacturing
  • artificial intelligence
  • cell biology
  • climatic change mitigation
  • computational intelligence
  • diabetes
  • diagnostic imaging
  • drug discovery
  • drug safety
  • electrochemistry
  • implants
  • lipids
  • medicinal chemistry

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime